Dihydropyrimidinones as Potent Anticancer Agents

Dihydropyrimidinones as Potent Anticancer Agents gives readers a unique update on scientific knowledge, accomplishments and recent advances in the medicinal chemistry of dihydropyrimidinones in cancer treatment. Dihydropyrimidinones are known to be active scaffold and have been reported to show some exceptional results with regards to malignancies. With ever increasing knowledge and information about synthesis, pharmacology and other aspects of dihydropyrimidinones there is need to document such information in one place. Since the field of medicinal chemistry is dynamic, with new emerging trends, it provides readily available updated information on chemistry and pharmacology aspects of dihydropyrimidinones in cancerThis book covers everything about dihydropyrimidinones from synthesis, derivatives, mode of action and potential therapeutic targets. It will also provide insights about the clinical trials and way forward in cancer research of dihydropyrimidinones. The most common issue that readers encounter is a lack of comprehensive understanding about a topic in a single book. This book may be able to help with this issue because it covers everything from the fundamentals of dihydropyrimidinones to the latest breakthroughs in clinical trials, as well as future prospects in cancer treatment. Covers dihydropyrimidinones synthesis, derivatives, and mode of action Includes recent advances in dihydropyrimidinones for cancer treatment Highlights potential therapeutic targets INDICE: 1. Introduction of Dihydropyrimidinones: Medicinal Chemistry Perspective2. Synthetic strategies of dihydropyrimidinones.3. Biological activities of dihydropyrimidinones.4. Dihydropyrimidinones Scaffold and potential therapeutic targetsDr. Amita Verma, Bioorganic and Medicinal Chemistry Research Laboratory5. Dihydropyrimidinones Scaffold and potential anticancer targets.6. Dihydropyrimidinones inhibits proliferation and tumour growth.7. Novel Dihydropyrimidinones as potential cytotoxic agents in hepatocellular carcinomas8. Applications of dihydropyrimidinone derivatives on blood cancer and colon cancer. 9. Therapeutic efficacy of dihydropyrimidinone in triple-negative breast cancer10. Dihydropyrimidone derivaives with anticancer activity in clinical trialsRecent advances of Dihydropyrimidinone derivatives in cancer research

• ISBN: 978-0-443-19094-0
• Editorial: Elsevier
• Encuadernacion: Rústica
• Páginas: 450
• Fecha Publicación: 01/08/2023
• Nº Volúmenes: 1
• Idioma: Inglés